Variant report
Variant | nsv1022312 |
---|---|
Chromosome Location | chr7:13561595-13576298 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12699509 | chr7:13561595-13561596 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs183001289 | chr7:13561621-13561622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552338661 | chr7:13561700-13561701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368068056 | chr7:13561708-13561709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569240992 | chr7:13561768-13561769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571661471 | chr7:13561795-13561796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540636753 | chr7:13561804-13561805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149689880 | chr7:13561821-13561822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115571515 | chr7:13561850-13561851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543584012 | chr7:13561857-13561858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563375339 | chr7:13561886-13561887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4445120 | chr7:13561891-13561892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4721234 | chr7:13561898-13561899 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs185012275 | chr7:13561915-13561916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568575420 | chr7:13561934-13561935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374817366 | chr7:13561938-13561939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190992865 | chr7:13561978-13561979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78432333 | chr7:13561997-13561998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568644552 | chr7:13562037-13562038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113396521 | chr7:13562069-13562070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539779788 | chr7:13562111-13562112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145517394 | chr7:13562148-13562149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570201882 | chr7:13562165-13562166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs28410483 | chr7:13562215-13562216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2723487 | chr7:13562234-13562235 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs13238361 | chr7:13562235-13562236 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs540599414 | chr7:13562279-13562280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12533864 | chr7:13562308-13562309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148864139 | chr7:13562313-13562314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369659364 | chr7:13562335-13562336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76471762 | chr7:13562340-13562341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543396788 | chr7:13562390-13562391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34817842 | chr7:13562395-13562396 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs529037587 | chr7:13562405-13562406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112089680 | chr7:13562409-13562410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187600550 | chr7:13562453-13562454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562134366 | chr7:13562499-13562500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192130152 | chr7:13562550-13562551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370750855 | chr7:13562568-13562569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183241671 | chr7:13562571-13562572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527813636 | chr7:13562580-13562581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201702770 | chr7:13563016-13563017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146506005 | chr7:13563032-13563033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556939550 | chr7:13563040-13563041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184620519 | chr7:13563061-13563062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542821048 | chr7:13563073-13563074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574279449 | chr7:13563099-13563100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188209448 | chr7:13563128-13563129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540095873 | chr7:13563138-13563139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141095604 | chr7:13563146-13563147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:13559000-13562200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr7:13562200-13562600 | Enhancers | Pancreas | Pancrea |
3 | chr7:13563000-13563600 | Enhancers | Fetal Brain Female | brain |
4 | chr7:13563200-13563600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr7:13563200-13563800 | Enhancers | Fetal Lung | lung |
6 | chr7:13563200-13564000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr7:13563200-13564800 | Enhancers | Osteobl | bone |
8 | chr7:13563400-13563600 | Enhancers | NHDF-Ad | bronchial |
9 | chr7:13563400-13564800 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr7:13563400-13564800 | Enhancers | Adipose Nuclei | Adipose |
11 | chr7:13564400-13564800 | Enhancers | Liver | Liver |
12 | chr7:13564600-13565000 | Active TSS | Pancreatic Islets | Pancreatic Islet |
13 | chr7:13564800-13565200 | Enhancers | NHDF-Ad | bronchial |
14 | chr7:13566800-13567200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr7:13567600-13568000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr7:13570800-13571800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr7:13571000-13571400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
18 | chr7:13571000-13571400 | Enhancers | H1 Cell Line | embryonic stem cell |
19 | chr7:13571000-13571400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr7:13571200-13571800 | Enhancers | H9 Cell Line | embryonic stem cell |
21 | chr7:13571200-13571800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
22 | chr7:13575400-13576000 | Enhancers | Muscle Satellite Cultured Cells | -- |
23 | chr7:13576000-13580200 | Weak transcription | Muscle Satellite Cultured Cells | -- |